Ind

(redirected from Investigational New Drug)
Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.

Ind

(ɪnd)
n
1. (Placename) a poetic name for India
2. (Placename) an obsolete name for the Indies

IND

abbreviation for
1. (Roman Catholic Church) Also: IDN in nomine Dei
2. (Automotive Engineering) India (international car registration)
[(for sense 1) Latin: in the name of God]

Ind

(ɪnd)

n.
1. Archaic. India.
2. Obs. the Indies.

ind-

var. of indo- before a vowel: indamine.

IND

investigative new drug.

Ind.

1. India.
2. Indiana.
3. Indies.

ind.

1. independent.
2. index.
3. indicative.
4. industry.
References in periodicals archive ?
Zosano Pharma Corporation announced that the Company has submitted an Investigational New Drug application to the U.S.
M2 EQUITYBITES-July 16, 2019-US FDA grants investigational new drug approval for Sensorion to proceed with SENS-401
M2 PHARMA-July 16, 2019-US FDA grants investigational new drug approval for Sensorion to proceed with SENS-401
Global Banking News-February 12, 2019-BioArctic reports approval by US FDA of Investigational New Drug Application for ABBV-0805
FOLSOM, Calif., August 22, 2018 -- StemExpress has released its clinical grade nontransfusable products to researchers and clinicians developing studies related to transplantation, cell therapy, regenerative medicine, investigational new drug development and medical devices in preclinical and clinical phases.
"For medicines that ultimately receive FDA approval, these findings suggest that the FDA and pharmaceutical industry have established a balance between investigational new drug access and protection of patients from therapies without established safety," the authors write.
The policy applies to all phase I-IV clinical trials that are conducted for the prevention, detection, or treatment of cancer or other life-threatening diseases, including federally funded trials, investigational new drug applications reviewed by the Food and Drug Administration, or drug trials that are exempt from having an investigational new drug application.
The US Food and Drug Administration (FDA) has accepted an application from Galapagos to open an investigational new drug dossier.
Investigational new drug (IND) applications are submitted to the FDA prior to the onset of clinical trials.
FDA will have oversight of the manufacture of these drugs under its general statutory CGMP authority and review of investigational new drug applications.
government for use in the event of an emergency, as an FDA investigational new drug.

Full browser ?